PubMed

Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo.

Ring DB, Johnson KW, Henriksen EJ, Nuss JM, Goff D, Kinnick TR, Ma ST, Reeder JW, Samuels I, Slabiak T, Wagman AS, Hammond ME, Harrison SD.

Diabetes. 2003 Mar;52(3):588-95.PMID: 12606497 [PubMed - indexed for MEDLINE]Related articlesFree article

Short-term in vitro inhibition of glycogen synthase kinase 3 potentiates insulin signaling in type I skeletal muscle of Zucker Diabetic Fatty rats.

Henriksen EJ, Teachey MK.

Metabolism. 2007 Jul;56(7):931-8.PMID: 17570255 [PubMed - indexed for MEDLINE]Related articlesFree article

Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats.

Henriksen EJ, Kinnick TR, Teachey MK, O'Keefe MP, Ring D, Johnson KW, Harrison SD.

Am J Physiol Endocrinol Metab. 2003 May;284(5):E892-900. Epub 2003 Jan 7.PMID: 12517738 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats.

Cline GW, Johnson K, Regittnig W, Perret P, Tozzo E, Xiao L, Damico C, Shulman GI.

Diabetes. 2002 Oct;51(10):2903-10.PMID: 12351425 [PubMed - indexed for MEDLINE]Related articlesFree article

Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3.

Dokken BB, Saengsirisuwan V, Kim JS, Teachey MK, Henriksen EJ.

Am J Physiol Endocrinol Metab. 2008 Mar;294(3):E615-21. Epub 2007 Dec 18.PMID: 18089761 [PubMed - indexed for MEDLINE]Related articlesFree article

Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.

Dokken BB, Sloniger JA, Henriksen EJ.

Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1188-94. Epub 2005 Jan 25.PMID: 15671078 [PubMed - indexed for MEDLINE]Related articlesFree article

Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.

Dokken BB, Henriksen EJ.

Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E207-13. Epub 2006 Feb 14.PMID: 16478771 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor.

Ruzzin J, Wagman AS, Jensen J.

Diabetologia. 2005 Oct;48(10):2119-30. Epub 2005 Aug 3.PMID: 16078016 [PubMed - indexed for MEDLINE]Related articles

Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.

Nikoulina SE, Ciaraldi TP, Mudaliar S, Carter L, Johnson K, Henry RR.

Diabetes. 2002 Jul;51(7):2190-8.PMID: 12086949 [PubMed - indexed for MEDLINE]Related articlesFree article

Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR.

Diabetes. 2000 Feb;49(2):263-71.PMID: 10868943 [PubMed - indexed for MEDLINE]Related articlesFree article

Essential role of p38 MAPK for activation of skeletal muscle glucose transport by lithium.

Harrell NB, Teachey MK, Gifford NJ, Henriksen EJ.

Arch Physiol Biochem. 2007 Oct-Dec;113(4-5):221-7.PMID: 18158645 [PubMed - indexed for MEDLINE]Related articles

Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.

Henriksen EJ, Dokken BB.

Curr Drug Targets. 2006 Nov;7(11):1435-41. Review.PMID: 17100583 [PubMed - indexed for MEDLINE]Related articles

Roles of insulin signalling and p38 MAPK in the activation by lithium of glucose transport in insulin-resistant rat skeletal muscle.

Macko AR, Beneze AN, Teachey MK, Henriksen EJ.

Arch Physiol Biochem. 2008 Dec;114(5):331-9.PMID: 19023684 [PubMed - indexed for MEDLINE]Related articlesFree article

Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.

Pearce NJ, Arch JR, Clapham JC, Coghlan MP, Corcoran SL, Lister CA, Llano A, Moore GB, Murphy GJ, Smith SA, Taylor CM, Yates JW, Morrison AD, Harper AJ, Roxbee-Cox L, Abuin A, Wargent E, Holder JC.

Metabolism. 2004 Oct;53(10):1322-30.PMID: 15375789 [PubMed - indexed for MEDLINE]Related articles

Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action.

Patel S, Doble BW, MacAulay K, Sinclair EM, Drucker DJ, Woodgett JR.

Mol Cell Biol. 2008 Oct;28(20):6314-28. Epub 2008 Aug 11.PMID: 18694957 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.

Kaidanovich-Beilin O, Eldar-Finkelman H.

J Pharmacol Exp Ther. 2006 Jan;316(1):17-24. Epub 2005 Sep 16.PMID: 16169938 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3.

Plotkin B, Kaidanovich O, Talior I, Eldar-Finkelman H.

J Pharmacol Exp Ther. 2003 Jun;305(3):974-80. Epub 2003 Mar 6.PMID: 12626660 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.

MacAulay K, Hajduch E, Blair AS, Coghlan MP, Smith SA, Hundal HS.

Eur J Biochem. 2003 Sep;270(18):3829-38.PMID: 12950267 [PubMed - indexed for MEDLINE]Related articlesFree article

Unlike insulin, amino acids stimulate p70S6K but not GSK-3 or glycogen synthase in human skeletal muscle.

Liu Z, Wu Y, Nicklas EW, Jahn LA, Price WJ, Barrett EJ.

Am J Physiol Endocrinol Metab. 2004 Apr;286(4):E523-8. Epub 2003 Dec 2.PMID: 14656717 [PubMed - indexed for MEDLINE]Related articlesFree article

v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats.

Maier VH, Melvin DR, Lister CA, Chapman H, Gould GW, Murphy GJ.

Diabetes. 2000 Apr;49(4):618-25.PMID: 10871200 [PubMed - indexed for MEDLINE]Related articlesFree article